Register Login

Cabaletta Bio Inc (CABA)

  • Event
  • May 12, 2022, 11:07 UTC

(90% Positive) CABALETTA BIO, INC. (CABA) Announces Enrollment Update for results Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Oct. 1, 2025, 2:41 p.m.

    📋 CABALETTA BIO, INC. (CABA) - Clinical Trial Update

    Filing Date: 2022-05-12

    Accepted: 2022-05-12 07:07:03

    Event Type: Clinical Trial Update

    Event Details:

    Cabaletta Bio Inc (CABA) Announces Clinical Trial Update Cabaletta Bio Inc (CABA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: results, responses
    • Clinical Stage: Phase 1 trial, Phase 1
    • Collaboration: SID Annual Meetings

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Cabaletta Bio Inc
    • CIK: 0001759138
    • Ticker Symbol: CABA
    • Period End Date: 2022-05-12
    • Document Type: 8-K

Search

News categories